Foundation Medicine, Inc.
(NASDAQ : FMI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.03%358.421.2%$822.65m
AMGNAmgen Inc.
-0.43%191.971.2%$549.69m
CELGCelgene Corporation
-0.11%85.691.2%$541.75m
GILDGilead Sciences, Inc.
0.68%77.640.9%$485.98m
SRPTSarepta Therapeutics, Inc.
-0.62%134.5116.6%$345.10m
VRTXVertex Pharmaceuticals Incorporated
-0.23%180.721.9%$321.35m
REGNRegeneron Pharmaceuticals, Inc.
0.12%366.422.6%$293.85m
ILMNIllumina, Inc.
0.79%309.723.5%$269.35m
BLUEBluebird Bio, Inc.
0.06%179.6515.7%$208.27m
NKTRNektar Therapeutics
1.82%48.755.6%$178.62m
ALXNAlexion Pharmaceuticals, Inc.
-0.37%135.152.0%$175.76m
FMIFoundation Medicine, Inc.
0.09%136.938.8%$160.93m
EXASExact Sciences Corporation
0.81%67.2825.4%$160.59m
EXELExelixis, Inc.
0.05%21.346.4%$135.83m
AAgilent Technologies, Inc.
2.03%64.271.5%$132.91m

Company Profile

Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. Its products includes: FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers; FoundationACT; and FoundationFocus CDxBRCA. The company was founded by Alexis Borisy in November 2009 and is headquartered in Cambridge, MA.